Arkolith/Insider Trading/QNRX/Form 4

Langer Dennis

DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4 · filed Oct 15, 2025
Net Buying
Open-Market Buys
$129K
Open-Market Sells
$0
Net Open-Market Flow
$129K
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 14, 2025Buy(P)15K$8.49$129K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 14, 2025Buy(P)15K——15K
Oct 14, 2025Buy(P)15K——15K
Oct 14, 2025Buy(P)15K——15K
Oct 14, 2025Buy(P)15K——15K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-099782) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML